Mayukh Dealtrade Ltd

Sattva Sukun Lifecare Limited has officially changed its name to Tavexia Lifecare Limited. The Ministry of Corporate Affairs has approved the name change and issued a fresh Certificate of Incorporation. The BSE Limited has also approved the application for the name change. The company will now be known as Tavexia Lifecare Limited. This change is effective from August 14, 2026. The company must display its old name alongside the new name for two years.

Sattva Sukun Lifecare Ltd announced that its Board of Directors met on August 4, 2026, to approve the un-audited financial results for the first quarter ended June 30, 2026. The results were prepared on a standalone and consolidated basis and have undergone a limited review by the statutory auditors, M/s. SSRV & Associates. The board also reviewed a statement of deviation(s) or variation(s) regarding the use of proceeds from a recent right issue.

Sattva Sukun Lifecare Limited announced that its Board of Directors, in a meeting held on August 4, 2026, approved the Un-Audited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2026. The board also took on record the Limited Review Report from the statutory auditors, SSRV & Associates. Additionally, the board considered and recorded a statement of deviation(s) or variation(s) regarding the use of proceeds from its Right Issue offer document.

Sattva Sukun Lifecare Ltd (formerly Mayukh Dealtrade Limited) has announced a Board of Directors meeting scheduled for August 4, 2026. The primary agenda is to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, along with the limited review report. The board will also discuss the utilization of funds from the recent rights issue and present any deviations. Additionally, the company confirmed the closure of the trading window for designated persons from April 1, 2026, until 48 hours after the board meeting.

Sattva Sukun Lifecare Ltd has issued a corrigendum to the notice of its Extra-Ordinary General Meeting (EOGM) originally dated June 30, 2026. The corrigendum, approved by the Board of Directors on July 17, 2026, addresses an amendment to agenda item 03 concerning the company's name change. Specifically, it substitutes the existing annexure related to a chartered accountant's certificate for compliance with SEBI LODR Regulations, 2015. This amendment is in response to queries from BSE Ltd. regarding the in-principle application for the company's name change. The EOGM, scheduled for July 22, 2026, will now proceed with the revised annexure. The company is also changing its name from 'Sattva Sukun Lifecare Limited' to 'Tavexia Lifecare Limited'.

Sattva Sukun Lifecare Ltd announced that its Board of Directors, in a meeting held on July 17th, 2026, approved a corrigendum to the Notice of an Extra-Ordinary General Meeting (EOGM). This corrigendum addresses a query from BSE Ltd. regarding the company's in-principle application for a name change. The EOGM, scheduled for July 22nd, 2026, will now include a revised annexure for Resolution No. 3, which pertains to the approval for changing the company's name from 'Sattva Sukun Lifecare Limited' to 'Tavexia Lifecare Limited' and consequential alterations to its Memorandum and Articles of Association.

Sattva Sukun Lifecare Ltd has issued a notice for an Extra Ordinary General Meeting (EOGM) to be held on Wednesday, July 22nd, 2026, at 02:00 P.M. IST through Video Conferencing/Other Audio Visual Means. The primary agenda items are the regularization of the appointment of Mr. Sachin Bhanubhai Manseta as a Non-Executive Independent Director and Mr. Chirag Dedhia as a Non-Executive Non-Independent Director. The notice, in compliance with SEBI Listing Regulations, is also available on the company's website.

Sattva Sukun Lifecare Ltd announced a board meeting where several key decisions were made. The company approved the shifting of its registered office within Mumbai, effective July 1, 2026. Additionally, the board considered and approved the regularization of two directors, Mr. Sachin Bhanubhai Manseta and Mr. Chirag Dedhia, subject to shareholder approval. A significant proposal was the change of the company's name to 'Tavexia Lifecare Limited' or similar, pending regulatory approval. The board also approved alterations to the Memorandum of Association's object clause and announced an Extra-Ordinary General Meeting (EGM) for shareholders to vote on these matters. Mr. Brajesh Gupta was appointed as the scrutinizer for the e-voting process.

Sattva Sukun Lifecare Ltd announced outcomes of its board meeting held on June 30, 2026. Key decisions include the proposed regularization of Mr. Sachin Bhanubhai Manseta and Mr. Chirag Dedhia as directors, subject to shareholder approval. The company also approved a significant rebranding initiative, proposing to change its name to Tavexia Lifecare Limited, Trumaxa Lifecare Limited, Trustarex Lifecare Limited, or Tradamex Life Care Limited, pending regulatory approval. Additionally, the board approved alterations to the Memorandum of Association and the shifting of its registered office within Mumbai, effective July 1, 2026. An Extra-Ordinary General Meeting (EGM) notice was also approved, with Mr. Brajesh Gupta appointed as Scrutinizer for e-voting.

Sattva Sukun Lifecare Ltd announced a board meeting held on June 30, 2026, where several key decisions were made. The company proposed a change in its name to Tavexia Lifecare Limited, Trumaxa Lifecare Limited, Trustarex Lifecare Limited, or Tradamex Life Care Limited, subject to regulatory approval. Additionally, the board approved alterations to the company's Object Clause in the Memorandum of Association. The meeting also covered the regularization of Mr. Sachin Bhanubhai Manseta and Mr. Chirag Dedhia as directors, subject to shareholder approval. The notice for an Extra-Ordinary General Meeting (EOGM) was approved, and Mr. Brajesh Gupta was appointed as Scrutinizer for the e-voting process.